168 related articles for article (PubMed ID: 23292493)
21. Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.
Zhou J; Gan N; Zhang W; Lu W; Xie X
J Obstet Gynaecol Res; 2010 Apr; 36(2):232-8. PubMed ID: 20492371
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
Guo F; Tian J; Cui M; Fang M; Yang L
Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
[TBL] [Abstract][Full Text] [Related]
23. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
24. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
25. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
Liu X; Wang A; Gao H; Yuan Z; Jiao Y
Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
[TBL] [Abstract][Full Text] [Related]
26. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
27. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
28. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
29. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
30. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
Law AY; Wong CK
Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
[TBL] [Abstract][Full Text] [Related]
31. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
33. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
34. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.
Jiang L; Luo RY; Yang J; Cheng YX
Mol Med Rep; 2013 Feb; 7(2):425-30. PubMed ID: 23229441
[TBL] [Abstract][Full Text] [Related]
36. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
Leong CT; Ong CK; Tay SK; Huynh H
Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
[TBL] [Abstract][Full Text] [Related]
37. [Influence of EphA2 siRNA transfection on the biological behavior of human ovarian carcinoma cell].
Han LP; Li MM; Zhang XX; Geng LN; Suo ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):877-81. PubMed ID: 24490493
[TBL] [Abstract][Full Text] [Related]
38. The anti-cancer activity of Antrodia camphorata against human ovarian carcinoma (SKOV-3) cells via modulation of HER-2/neu signaling pathway.
Yang HL; Lin KY; Juan YC; Kumar KJ; Way TD; Shen PC; Chen SC; Hseu YC
J Ethnopharmacol; 2013 Jun; 148(1):254-65. PubMed ID: 23619020
[TBL] [Abstract][Full Text] [Related]
39. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Yu J; Han Q; Cui Y
Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
[TBL] [Abstract][Full Text] [Related]
40. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.
Zhang F; Yang B; Shi S; Jiang X
Acta Histochem; 2014 Jul; 116(6):1000-6. PubMed ID: 24831064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
